Innovita Biological Technology Co., Ltd. (SHA:688253)

SHA:688253 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	430.96	621.39	478.02	446.62	326.91	1,037
Revenue Growth (YoY)	-40.18%	29.99%	7.03%	36.62%	-68.48%	651.46%
Cost of Revenue	99.98	127.53	140.51	173.94	77.24	112.36
Gross Profit	330.99	493.86	337.51	272.67	249.67	924.74
Selling, General & Admin	139.06	149.62	99.11	90.84	83.96	153.41
Research & Development	96.73	97.17	53.11	72.18	31.11	59.41
Other Operating Expenses	3.56	3.01	1.44	8.89	2.87	8.15
Operating Expenses	230.33	253.83	158.57	178.08	117.58	221.05
Operating Income	100.66	240.03	178.94	94.59	132.09	703.68
Interest Expense	-0.02	-0.11	-0.2	-0.41	-0.13	-0.18
Interest & Investment Income	20.13	30.74	24.57	12.11	3.59	4.12
Currency Exchange Gain (Loss)	1.14	1.14	0.57	42.65	-9.76	-34.85
Other Non Operating Income (Expenses)	8.48	-3.92	0.34	-0.6	-0.11	-0.08
EBT Excluding Unusual Items	130.39	267.87	204.22	148.35	125.68	672.7
Gain (Loss) on Sale of Investments	10.4	7.46	9.15	2.23	0.89	0.12
Gain (Loss) on Sale of Assets	-0.1	-0.1	-0.01	0.01	-	-
Asset Writedown	-2.15	-	-19.54	-	-0	-0.09
Other Unusual Items	1.86	1.29	4.54	13.92	11.24	1.71
Pretax Income	140.39	276.53	198.36	164.51	137.81	674.45
Income Tax Expense	6.95	29.67	24.41	13.82	17.65	102.64
Earnings From Continuing Operations	133.44	246.86	173.95	150.68	120.16	571.81
Minority Interest in Earnings	-	-	-	-	0.09	-0.36
Net Income	133.44	246.86	173.95	150.68	120.25	571.45
Net Income to Common	133.44	246.86	173.95	150.68	120.25	571.45
Net Income Growth	-59.81%	41.92%	15.44%	25.31%	-78.96%	2584.36%
Shares Outstanding (Basic)	137	136	136	122	102	99
Shares Outstanding (Diluted)	137	136	136	122	102	99
Shares Change (YoY)	0.41%	0.36%	11.83%	19.24%	2.90%	286.30%
EPS (Basic)	0.97	1.81	1.28	1.24	1.18	5.77
EPS (Diluted)	0.97	1.81	1.28	1.24	1.18	5.77
EPS Growth	-59.97%	41.41%	3.23%	5.08%	-79.55%	594.89%
Free Cash Flow	137.04	269.31	242.89	68.71	42.52	563.1
Free Cash Flow Per Share	1.00	1.98	1.79	0.56	0.42	5.69
Dividend Per Share	0.560	0.560	0.400	0.166	-	-
Dividend Growth	40.00%	40.00%	140.96%	-	-	-
Gross Margin	76.80%	79.48%	70.60%	61.05%	76.37%	89.17%
Operating Margin	23.36%	38.63%	37.43%	21.18%	40.41%	67.85%
Profit Margin	30.96%	39.73%	36.39%	33.74%	36.79%	55.10%
Free Cash Flow Margin	31.80%	43.34%	50.81%	15.38%	13.01%	54.30%
EBITDA	116.89	258.72	200.92	111.08	145.29	709.09
EBITDA Margin	27.12%	41.64%	42.03%	24.87%	44.45%	68.37%
D&A For EBITDA	16.23	18.7	21.98	16.49	13.21	5.4
EBIT	100.66	240.03	178.94	94.59	132.09	703.68
EBIT Margin	23.36%	38.63%	37.43%	21.18%	40.41%	67.85%
Effective Tax Rate	4.95%	10.73%	12.31%	8.40%	12.80%	15.22%
Revenue as Reported	100.57	621.39	478.02	446.62	326.91	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.